Geneva Advisors’s Lydall, Inc. LDL Stock Holding History
Bought
Maintained
Sold
Other funds holding LDL
CIP
AR
RA
Geneva Advisors's LDL Position: Q2 2017 in Review
Geneva Advisors increased its Lydall, Inc. (LDL) stake by 4% in Q2 2017, buying an estimated $31.8K and bringing the position to 16,140 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #399.
Geneva Advisors first reported a position in LDL in Q1 2016 and has held it in 6 quarters since. The position peaked at $1.27M in Q4 2016. 147 funds tracked by Wall St. Rank hold LDL as of Q2 2017.
- Geneva Advisors held 16,140 shares of Lydall, Inc. worth $834K as of Q2 2017.
- Geneva Advisors bought 617 Lydall, Inc. shares in Q2 2017, an estimated $31.8K.
- Lydall, Inc. made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #399 holding.
- Geneva Advisors first reported a position in Lydall, Inc. in Q1 2016 and has held it in 6 quarters since.
- Geneva Advisors's Lydall, Inc. position peaked at $1.27M in Q4 2016.
- 147 funds tracked by Wall St. Rank held Lydall, Inc. as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.